Chromium picolinate for reducing body weight: Meta-analysis of randomized trials
The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Abstract
The aim of this meta-analysis was to assess the evidence of chromium picolinate for reducing body weight. Literature searches were conducted on Medline, Embase, The Cochrane Library, Amed and Ciscom. Nine experts and four manufacturers of commercial preparations containing chromium picolinate were asked to contribute published and unpublished studies. There were no restrictions regarding the language of publication. The screening of studies, selection, data extraction, validation and the assessment of methodological quality were performed independently by two reviewers. To be included, studies were required to state that they were randomized, double-blind and placebo-controlled, and report on body weight. Ten trials met all inclusion criteria and provided data, which were suitable for statistical pooling. For body weight a significant differential effect was found in favour of chromium picolinate (weighted mean difference: -1.1 kg; 95% confidence interval (CI): -1.8 to -0.4 kg, n=489). Sensitivity analysis suggests that this effect is largely dependent on the results of a single trial (weighted mean difference: -0.9 kg; 95% CI: -2.0 to 0.2 kg, n=335). Three of the reviewed trials reported on adverse events, indicating their absence in the treatment groups. In conclusion, our meta-analysis suggests a relatively small effect of chromium picolinate compared with placebo for reducing body weight. The clinical relevance of the effect is debatable and the lack of robustness means that the result has to be interpreted with caution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with a relatively small effect on reducing body mass in humans [193]”
From The Role of Mineral and Trace Element Supplementation in Exercise and Athletic Performance: A Systematic Review (2019) · cites this paper as [193]
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998) · JAMA · doi:10.1001/jama.280.18.1569 · Cited by 6,658
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694
The Existence of Publication Bias and Risk Factors for Its Occurrence
Dickersin, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440100097014 · Cited by 1,417
Variance imputation for overviews of clinical trials with continuous response
Follmann, D., Elliott, P., Suh, I., & Cutler, J. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90054-q · Cited by 1,385
meta-analysis bias in location and selection of studies
Egger, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7124.61 · Cited by 1,374
Research works printed but not linked: 4
- Trent LK, Thieding-Cancel D . Effect of chromium picolinate on body composition. J Sports Med Phys Fitness 1995; 35: 273–280.
- Ravina A, Slezak L, Rubal A, Mirsky N . Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elements Exp Med 1995; 8: 183–190.
- Bahadori B, Wallner S, Schneider H, Wascher TC, Toplak H . Effekt von Chromhefe und Chrompicolinat auf die Körperzusammensetzung bei übergewichtigen, nichtdiabetischen Patienten während und nach einer Formula-Diät. Acta Med Aust 1997; 24: 185–187.
- Evans GW . The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosocial Med Res 1989; 11: 163–180.
Cited by
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,885
“In addition, a meta-analysis of randomized controlled trials suggested no benefit of chromium picolinate supplementation in reducing body weight (51).”
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
“Similarly, a meta-analysis of randomized controlled trials failed to demonstrate any benefit of chromium picolinate supplementation in reducing body weight (81).”
BackgroundManna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
“A few clinical studies have reported the weight-lowering effect of chromium supplementation.(375,376) Dietary consumption of more fruits and vegetables is also associated with a decrease in the prevalence of obesity.”
BackgroundRole of Chromium in Human Health and in Diabetes
Cefalu, W. T., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2741 · Cited by 590
“Recent meta-analyses (33,34) of results from studies that evaluated the effects of chromium supplementation have suggested limited benefit in individuals with or without diabetes.”
BackgroundChromium as an essential nutrient: a review
Pechova, A., & Pavlata, L. (2007) · Veterinární medicína · doi:10.17221/2010-vetmed · Cited by 439
“Pitler et al. (2003) published results of a meta-analysis whose aim was to assess the evidence of the effect of chromium picolinate for reducing body weight.”
Result
Metadata
- Authors
- Pittler, M. H., Stevinson, C., & Ernst, E.
- Affiliations
- University of Exeter (GB)
- University of Bristol (GB)
- Corresponding author
- Pittler, M H
- ORCID
- Stevinson, C
- Venue
- International Journal of Obesity
- Published
- 2003-03-27
- Volume
- 27
- Issue
- 4
- Pages
- 522-529
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2132322696
- Cited by
- 131
- References
- 70
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 6
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Chromium effects and bioremediation
- Keywords
- chromium picolinate, weight loss, dietary supplements, obesity, placebo effect, adverse events
- MeSH terms
- Female, Humans, Iron Chelating Agents, Male, Obesity, Picolinic Acids, Randomized Controlled Trials as Topic, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromium picolinate for reducing body weight: Meta-analysis of randomized trials. https://app.cochat.ai/papers/10.1038/sj.ijo.0802262
- The paper
- Pittler, M. H., Stevinson, C., & Ernst, E. (2003). Chromium picolinate for reducing body weight: Meta-analysis of randomized trials. International Journal of Obesity. https://doi.org/10.1038/sj.ijo.0802262
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.